menin inhibitor

TURIN, Italy — September 29, 2026 Kither Biotech Pty Ltd and Kither Biotech Srl announced that the first patients...

SAN DIEGO — September 29, 2026 Caspian Therapeutics and Kura Oncology announced new preclinical data for KO-7246, an investigational,...

SAN DIEGO — September 9, 2026 Kura Oncology, Inc. announced the launch of Caspian Therapeutics, Inc., a separately financed...

SAN DIEGO, August 10, 2026 Kura Oncology, Inc. announced the publication of new research in Blood detailing the discovery...

MARLBOROUGH, Mass., July 30, 2026 Sumitomo Pharma America announced that the U.S. Food and Drug Administration (FDA) has granted...

NEW YORK, July 14, 2026 Syndax Pharmaceuticals unveiled two new pipeline candidates during its 2026 R&D Event, expanding its...

TOKYO & SAN DIEGO, April 24, 2026 Kyowa Kirin and Kura Oncology have announced a major clinical milestone with...

Cambridge, Massachusetts – September 2, 2025 Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene-editing biotechnology company, has nominated EDIT-401,...

Marlborough, Massachusetts – November 3, 2025 Sumitomo Pharma America, Inc. (SMPA) announced compelling new investigational data from multiple clinical...

SAN DIEGO and TOKYO, Oct. 1, 2025 — Kura Oncology and Kyowa Kirin have announced the first patient dosing...